325 related articles for article (PubMed ID: 20209481)
1. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
Kharroubi SA; O'Hagan A; Brazier JE
Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
[TBL] [Abstract][Full Text] [Related]
2. Bayesian nonparametric estimation of EQ-5D utilities for United States using the existing United Kingdom data.
Kharroubi SA
Health Qual Life Outcomes; 2017 Oct; 15(1):195. PubMed ID: 28985757
[TBL] [Abstract][Full Text] [Related]
3. Valuation of preference-based measures: can existing preference data be used to generate better estimates?
Kharroubi SA
Health Qual Life Outcomes; 2018 Jun; 16(1):116. PubMed ID: 29866108
[TBL] [Abstract][Full Text] [Related]
4. Valuations of EQ-5D health states: are the United States and United Kingdom different?
Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
6. Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS; Ray S; Ganguli A; Cella D
Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
[TBL] [Abstract][Full Text] [Related]
7. A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method.
Kharroubi SA; Brazier JE; McGhee S
Value Health; 2014 Jun; 17(4):397-405. PubMed ID: 24969000
[TBL] [Abstract][Full Text] [Related]
8. Estimation and comparison of EQ-5D health states' utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom.
Galante J; Augustovski F; Colantonio L; Bardach A; Caporale J; Marti SG; Kind P
Value Health; 2011; 14(5 Suppl 1):S60-4. PubMed ID: 21839901
[TBL] [Abstract][Full Text] [Related]
9. Italian population-based values of EQ-5D health states.
Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Japan and U.K. SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method.
Kharroubi SA
Appl Health Econ Health Policy; 2015 Aug; 13(4):409-20. PubMed ID: 25896874
[TBL] [Abstract][Full Text] [Related]
11. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
Zarate V; Kind P; Chuang LH
Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
[TBL] [Abstract][Full Text] [Related]
12. Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?
Kharroubi SA; Rowen D
Eur J Health Econ; 2019 Mar; 20(2):245-255. PubMed ID: 29980950
[TBL] [Abstract][Full Text] [Related]
13. Estimating an EQ-5D population value set: the case of Japan.
Tsuchiya A; Ikeda S; Ikegami N; Nishimura S; Sakai I; Fukuda T; Hamashima C; Hisashige A; Tamura M
Health Econ; 2002 Jun; 11(4):341-53. PubMed ID: 12007165
[TBL] [Abstract][Full Text] [Related]
14. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
15. Modelling a preference-based index for EQ-5D using a non-parametric Bayesian method.
Kharroubi SA; Daher CA
Qual Life Res; 2018 Nov; 27(11):2841-2850. PubMed ID: 30008157
[TBL] [Abstract][Full Text] [Related]
16. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
Whitehurst DG; Norman R; Brazier JE; Viney R
Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
[TBL] [Abstract][Full Text] [Related]
17. Modeling HUI 2 health state preference data using a nonparametric Bayesian method.
Kharroubi SA; McCabe C
Med Decis Making; 2008; 28(6):875-87. PubMed ID: 18971313
[TBL] [Abstract][Full Text] [Related]
18. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
[TBL] [Abstract][Full Text] [Related]
19. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations.
Dolan P; Roberts J
Med Care; 2002 May; 40(5):442-6. PubMed ID: 11961478
[TBL] [Abstract][Full Text] [Related]
20. National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.
Karlsson JA; Nilsson JÅ; Neovius M; Kristensen LE; Gülfe A; Saxne T; Geborek P
Ann Rheum Dis; 2011 Dec; 70(12):2163-6. PubMed ID: 21859684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
